Human dihydroorotate dehydrogenase (DHODH) is an integral protein of the inner mitochondrial membrane (IMM) that catalyzes the fourth step of the de novo pyrimidine biosynthesis and is functionally connected to the respiratory chain via its lipophilic co-substrate, ubiquinone Q 10 . DHODH is the target for drugs approved for the treatment of rheumatoid arthritis and multiple sclerosis, and mutations in its sequence have been identified as the cause of Miller syndrome, a rare genetic disorder. The N-terminus of DHODH consists of a signal peptide for mitochondrial import (MS), a transmembrane domain (TM), followed by a microdomain which interacts with the lipids of the IMM and has been proposed to form the binding site for ubiquinone Q 10 . However, the mechanism by which DHODH interacts with the membrane-embedded Q 10 and the lipids of the IMM remains unknown. We present the preparation and characterization of proteins necessary for investigating the structural interactions of DHODH with the lipids of the IMM, including expression and purification of full-length and N-terminally truncated (without MS and TM) DHODH. We characterized the interaction of truncated DHODH with lipid bilayers containing some key lipids of the IMM using Quartz Crystal Microbalance with Dissipation monitoring and compared it to the DHODH from E. coli, a DHODH that naturally lacks a TM. Our results suggest that although cardiolipin enhances the interaction of truncated DHODH with lipid bilayers, the presence of the TM in human DHODH is necessary for stable binding to and securing its location at the outer surface of the IMM.
Introduction
Human dihydroorotate dehydrogenase (DHODH; EC:1.3.5.2) is an integral protein of the inner mitochondrial membrane (IMM) that catalyzes the fourth step of the de novo pyrimidine biosynthesis and is functionally connected to the respiratory chain via ubiquinone Q 10 . [1] [2] [3] The structure and orientation of DHODH in the IMM are illustrated in Figure 1 . The N-terminus of DHODH contains a bipartite signal ( Figure 1 : Mitochondrial signal, MS, and transmembrane segment, TM) that determines its import and correct insertion into the IMM. [3] We have previously shown that deletion of the N-terminal sequence blocks DHODH import into mitochondria, whereas deletion of the TM results in import into the mitochondrial matrix instead of the IMM. [3] These N-terminal parts of DHODH are connected to the catalytic domain via two alpha helices (a1, a2) proposed to be critical for the interaction of DHODH with the IMM, and the electron acceptor ubiquinone Q 10 , and represent an important target for inhibitor binding. [4, 5] Crystal structures (see [6] for a recent listing) of the catalytic domain of DHODH exist but virtually no experimental structural data about the hydrophobic domain or the full-length membrane bound form has been obtained. CD and DEER spectroscopy have shown that the N-terminal alpha helices a1-a2 assume a different conformation in detergent micelles Figure 1 . Structure and orientation of human DHODH in the inner mitochondrial membrane (IMM) and schematic representation of the protein constructs used in this study. The N-terminus of DHODH contains a mitochondrial signal (MS) and a transmembrane segment (TM). These N-terminal segments are connected to the catalytic domain via two alpha helices (a1, a2) proposed to be critical for the interaction of DHODH with the IMM, and the electron acceptor cosubstrate ubiquinone Q 10 . The presumed location of Q 10 in the IMM is also shown. In this study, four constructs for human DHODH expression were tested as well as one construct for expression of E. coli DHODH (His-EcDHODH). All constructs were designed with either N-or C-terminal histidine tags (His) to allow protein purification by IMAC. The His-tag was followed by (N-terminal tag) or preceded by (C-terminal tag) a tobacco etch virus (TEV) protease cleavage site (not shown here) to allow removal of the tag. The numbering indicates the amino acid count based on the full-length human DHODH sequence (Uniprot Q02127 (PYRD_HUMAN)), also indicating the shorter length of the E. coli DHODH in comparison. and phospholipid vesicles, [7] indicating that the nature of the membrane may play a role in the structure adopted. Another open question is how the enzyme interacts with the ubiquinone Q 10 , which has been shown by neutron diffraction to be localized in the hydrophobic center of lipid membranes, [8] but is also thought to bind to the DHODH membrane-targeting microdomain. [9] Clinically used DHODH inhibitors such as the active metabolite of ARAVAV R or atovaquone, and the former candidate drug brequinar have also been shown to bind at this location [6] in N-terminal truncated DHODH forms, but it is less clear how they access it in the membrane-bound enzyme. Furthermore, certain mutations in human DHODH have been identified as the cause of Miller syndrome, [10, 11] a rare autosomal recessive disorder (OMIM %263750) and it is not known how mutations found in Millers syndrome influence the interaction of DHODH with the IMM or Q 10 .
Recently, it has been proposed that inhibitor binding to DHODH is influenced by interactions with lipids in the IMM. [12] This is supported by our previous findings showing differences in the inhibition of DHODH by brequinar depending on whether the TM is present or not. [4] In experiments with flies, we could also show that truncated DHODH (without MS and TM) could not support normal de novo pyrimidine biosynthesis during development of the fly (i.e., failure to complement dhod-null mutations), apparently due to instability of the truncated proteins. [13] Most studies of DHODH lipid interactions have used only peptides mimicking the a1-a2 domain of DHODH or N-terminally truncated (N-terminal His-tagged) DHODH lacking MS and TM. [7, 14] It is therefore of interest to understand the interaction of full-length DHODH and N-terminally truncated DHODH with lipids of the IMM and Q 10 . This could form the basis of an innovate approach to optimize DHODH inhibitor design in which the mitochondrial lipid environment of DHODH is taken into account, as it may influence the specificity or efficiency of different inhibitors.
We therefore aim to investigate the structures involved in the interactions of DHODH with lipids of the IMM and the mechanism of substrate/ inhibitor binding and effects of the mutations related to Millers syndrome using noninvasive methods that allow us to probe the interaction in-situ, under physiologically relevant conditions. As first steps toward this goal, we present here Quartz Crystal Microbalance with Dissipation monitoring (QCM-D) studies probing the interaction of DHODH with supported lipid bilayers in-situ. These results are a prerequisite for investigating the interaction of DHODH with IMM lipids using neutron reflectivity (NR). NR is a noninvasive surface scattering technique that can determine the one dimensional depth profile of single lipid membranes to 2-3 Å resolution, yielding the low-resolution structure-profile of embedded membrane proteins if selective deuterium labeling of either the protein or the lipids is used. [15] 2. Material and methods
Plasmids
Plasmids were purchased from Genscript (Hong Kong). All DHODH expression constructs were cloned into pET-26b (þ) (Novagen) using the NdeI/XhoI restriction sites and the inserts were codon optimized by GenScript (Hong Kong) for expression. A schematic presentation of the constructs is shown in Figure 1 . All plasmids were transformed into electrocompetent E. coli TUNER(DE3) cells (Novagen).
Protein expression
Of the 5 constructs presented in Figure 1 , DHODH-His, His-D29DHODH and His-EcDHODH were expressed and purified. The amino acid sequences and a sequence alignment of the protein products after purification can be found in the supplementary material ( Figure S1 , Supplementary material).
Precultures were inoculated with frozen glycerol stocks of the transformed bacteria and incubated overnight at 30 C and 200 rpm. The precultures were used to inoculate 2.5 L Tunair TM (IBI Scientific) flasks containing Terrific Broth (TB) supplemented with 50 mg/mL kanamycin. When the cultures reached an OD 600 of 0.6-0.8 units, protein expression was induced with isopropyl-b-D-thiogalactoside at either 100 mM for His-D29DHODH and His-EcDHODH or 20 mM for DHODH-His (Supplementary material, Table S1 ). At this point, the cultures were also supplemented with 100 mM of the sodium salt of flavin mononucleotide (FMN) (Sigma) and the temperature was decreased to 18 C. After 20 h, cells were harvested by centrifugation (8000 g, 20 min, 4 C). The bacterial pellets were kept frozen at À80 C until used.
Protein purification
The frozen bacterial pellets were thawed at room temperature and resuspended in Buffer A (50 mM sodium phosphate, 300 mM NaCl, 10% glycerol, 10 mM imidazole, pH 8.0) supplemented with Triton X-100 (0.1% v/v), DNase I (Applichem), lysozyme (Alfa Aesar) and EDTA-free protease inhibitors (Roche). In the case of full-length human DHODH-His, the lysis buffer was supplemented with 1% v/v Triton X-100. The cells were disrupted by passing them twice through a French pressure cell at 18 000 psig.
The crude lysate was clarified by centrifugation (20 000 Â g, 30 min, 4 C). The supernatant was filtered using a 0.45-mm cellulose acetate filter equipped with a glass wool prefilter. The filtrate was then passed through a 0.22-mm polyethersulfone filter. The filtered supernatant was loaded onto a 5 mL HisTrap HP column (GE Healthcare) equilibrated with 5 column volumes (CV) of Buffer A. In the case of full-length human DHODH, Buffer A was supplemented with dodecyl D-maltoside (DDM) at 5 times the critical micelle concentration (0.6 mM). The column was washed with 20 CV of the same buffer. The target protein was eluted with an imidazole gradient (10-500 mM) in Buffer A. DHODH typically eluted at imidazole concentrations in the 250-350 mM range. Eluted fractions containing the target protein were pooled together and placed in a Spectra/Por dialysis membrane with a molecular weight cutoff (MWCO) of 6-8 kDa. For removal of the His-tag, Tobacco etch virus (TEV) protease with a His-tag (LP3, Lund University) was added at a 1:10 TEV/protein mass ratio and the mixture was dialyzed overnight (16-18 h) at 18 C against 2 L of Buffer A supplemented with 1 mM dithiotreitol (DTT). The contents of the bag were passed through a 0.22 mm filter and applied onto a HisTrap HP column equilibrated with 5 CV of Buffer A. The flowthrough and wash fractions containing the cleaved protein with the His-tag removed were combined and concentrated to <5 mL with an Amicon centrifugal filter (MWCO 30 kDa). The concentrated protein solution was injected into a 26 Â 600 mm column packed with 320 mL of Superdex 200 pg (GE Healthcare) previously equilibrated with 1.5 CV of Buffer C (50 mM sodium phosphate, 400 mM NaCl, 10% glycerol, pH 7.4). Buffer C was supplemented with 0.6 mM DDM in the case of full-length DHODH. Size exclusion chromatography was performed in isocratic elution mode at a flowrate of 1.5 mL/min. Elution fractions containing the target protein were pooled together and concentrated to 5-10 mg/mL. The aliquots containing purified proteins were snap frozen with liquid nitrogen and stored at -80 C. Protein fractions from the purification procedure were analyzed by sodium dodecyl polyacrylamide gel electrophoresis (SDS-PAGE) using pre-cast Criterion TGX gels (BioRad). Protein concentration was determined by means of the bicinchoninic acid (BCA) assay using bovine serum albumin (BSA) as the standard.
Enzyme activity assay
DHODH activity was determined with a chromogen reduction assay. [1] The reaction mixture contained 1 mM L-dihydroorotate (DHO) (Sigma) and 0.1 mM decylubiquinone (Q D ) (Sigma) as the substrates, and 60 mM 2,6-dichlorophenolindophenol (DCIP) (Sigma) as the chromogen (e ¼ 18 800 M À1 ) dissolved in assay buffer (50 mM Tris-HCl pH 8.0, 150 mM KCl, 0.1% v/v Triton X-100). The reaction was initiated by mixing 200 mL of reaction mixture with 5-10 mL of enzyme in the wells of a flat-bottom 96-well plate (Nunc). The reduction of DCIP was monitored as a decrease in absorbance at 620 nm at 30 C using a FLUOstar Optima plate reader (BMG Labtech) in kinetic mode. One Unit (U) of enzyme activity is defined as the amount of enzyme required to convert 1 mmol of dihydroorotic acid into orotic acid at 30 C assuming an equimolar relationship between the reduction of DCIP and the oxidation of DHO.
Preparation of small unilamellar vesicles
1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC) and 1',3'-bis[1,2dioleoyl-sn-glycero-3-phospho]-glycerol sodium salt (tetraoleyl cardiolipin, TOCL) were purchased from Avanti Lipids and ubiquinone Q 10 from Sigma-Aldrich. Lipid stocks of POPC, TOCL and Q 10 dissolved in a mixture of chloroform/methanol (9:1 v/v) were mixed in glass vials and dried under a stream of nitrogen for at least 2 h. The resulting dry lipid film was resuspended in either ultrapure water (R ¼ 18.2 MX) or buffer (10 mM Tris-HCl, 100 mM NaCl, pH 7.4) to a concentration of 0.5 mg/mL. The following lipid mixtures were prepared: 100 mol% POPC, 90 mol% POPC þ 10 mol% Q 10 , 90 mol% POPC þ 10% TOCL, and 80 mol% POPC þ 10 mol% Q 10 þ 10 mol% TOCL. In the case of lipid mixtures containing charged phospholipids (e.g., TOCL), the buffer was supplemented with 2 mM CaCl 2 . The lipids were allowed to hydrate for at least 30 min at room temperature. Small unilamellar vesicles (SUVs) were prepared by sonicating the resuspended lipids with a Vibra-Cell VCX 130 tip sonicator (Sonics, USA) for 5 minutes at 35% amplitude with a 10 s on/off cycle.
Quartz crystal microbalance with dissipation monitoring (QCM-D)
QCM-D analysis was performed using a QSense Analyzer (Biolin Scientific). The sensor crystals used were silicon dioxide (QSX303) (Biolin Scientific). QCM-D is a surface technique that can provide information about the mass and viscoelastic properties of substances adsorbed on the surface of the quartz crystal. [16] When subjected to an alternating electric field, the quartz crystal oscillates at a fundamental frequency (usually 5 MHz), with several overtones or harmonics (3rd, 5th, 7th, 9th, 11th, 13th). When additional mass is deposited on the crystal, the oscillation frequency decreases proportionally. Variations in mass in the nanogram range can be detected using this technique. If the film is rigid (low dissipation value), for a given frequency overtone, the mass of the adsorbed film can be calculated using the Sauerbrey relation [16, 17] (Equation (1)):
where Df is the change in frequency (Hz), f 0 is the fundamental frequency, A is the surface area, m q is the shear modulus of quartz (2.95 Â 10 11 dyn/cm 2 ),is the density of quartz (2.65 g/cm 3 ) and Dm is the change in mass deposited on the crystal surface. [16] From Equation (1), Dm can be calculated as follows:
where Dm is the change in mass, C is the integrated QCM sensitivity (17.7 ng Hz À1 for a 5 MHz quartz crystal), Df is the change in frequency and n is the overtone number. [17] The energy dissipation parameter (DD) provides information about the viscoelasticity of the adsorbed material (i.e., whether it is rigid or flexible). A soft material, such as a highly hydrated film that damps the oscillation will give rise to a high dissipation, whereas a rigid material will display low dissipation values. The Sauerbrey equation is only valid for low dissipation values, [17] and the mass of flexible protein films must be calculated using the Voigt model, which takes into account the viscoelasticity of the film. The Voigt model considers all the frequencies and all the dissipations at the several overtones to calculate an average Dm value.
The surface coverage (C) in mmol m À2 of the lipid bilayer can be calculated as follows:
where MW is the molecular weight of the lipid, A m is the area per lipid molecule in Å 2 and N A is Avogadro's constant (6.0221409 Â 10 23 mol À1 ). Table S2 in the supplementary material lists the physical properties of the proteins and lipids studied. For the case of mixtures containing more than one lipid, the average molecular weight corresponding to the composition of the mixture was used. However, the measured Dm corresponds to the total mass of the film, including any water present, and the molecular area estimation does not apply if there are water-filled defects in the lipid bilayer. For the same reason, the equation is not applicable to highly hydrated protein films. The sensors were cleaned by sonication for 30 min in a 2% Neutracon solution (2% v/v Decon Neutracon in Milli-Q water), followed by rinsing and sonication (10 min) in ultrapure water three times, before drying with N2 gas and treatment in a residual Argon plasma cleaner (PDC-32G, Harrick) for 10 min to remove any traces of organic contaminants.
The flow cells of the QCM-D instrument were cleaned by 2% Decon Neutracon detergent, ethanol and degassed Milli-Q water.
All measurements were carried out at 30 C and the fundamental frequency and six overtone frequencies (3rd, 5th, 7th, 9th, 11th, 13th) were recorded. One milliliter of freshly sonicated lipid vesicles was injected into the flow cells at 100 mL/min using a peristaltic pump to form a supported lipid bilayer by vesicle fusion to the silica sensor surface. When the signal was stabilized, excess vesicles were removed by rinsing with degassed buffer at 200 mL/min until a stable lipid bilayer was obtained. A total of 0.4 mg of protein (either D29DHODH or EcDHODH) at 0.4 mg/mL in buffer was injected at a flowrate of 100 mL/min, followed by rinsing with buffer at 200 mL/min.
Results
Recombinant expression of mitochondrial DHODH has previously been reported in several publications and many expression hosts as exemplified by these references. [1, 18, 19] For our purposes, an inexpensive, fast and highyield producing system is required to produce both DHODH with the TM domain as well as without (N-terminally truncated). We therefore revisited DHODH expression in E. coli and tested 4 constructs of human DHODH with different length and different location of the affinity tags ( Figure 1 ) and one construct for E. coli DHODH. After testing different media (either Luria-Bertani or Terrific Broth), temperature (18 C or 30 C) and inducer concentration (0, 0.01, 0.05, 0.1, 0.5 and 1 mM IPTG), the best expression conditions were determined (Supplementary Table 1 ). DHODH-His (full length), His-D29DHODH (N-terminally truncated) and His-EcDHODH (E. Coli) were chosen for large-scale expression and purification. The DHODH from E. coli is the prototype of the DHODH family 2, [20] and naturally lacks a TM domain but nevertheless uses ubiquinone as electron acceptor. We hypothesized that comparing the lipid interactions of the E. coli enzyme with the human enzyme might shed light on the evolution and role of the membrane anchoring of human DHODH. A comparison of the sequences of these proteins is shown in the supplementary material ( Figure S1, Supplementary material) .
All three proteins were purified to apparent homogeneity using immobilized metal (Ni 2þ ) affinity chromatography (IMAC), followed by cleavage of the His-tag with TEV protease, a second IMAC step, and finally size exclusion chromatography. Representative purification tables and SDS-PAGE analyses are presented in Table 1 and Figure 2 , respectively. The specific activities for D29DHODH (94.4 U/mg) and EcDHODH (51.8 U/mg) are very close to previously reported values for similar constructs of 107 U/mg [4] and 58 U/mg, [20] respectively. The specific activity for full-length DHODH (69.1 U/mg) was lower than previously reported activity on a similar construct with up to 150 U/mg. [18] However, in our current study, we solubilized the protein with DDM instead of Triton X-100. This difference in specific activities might be due to the detergent environment of the TM and membrane interacting parts of DHODH.
We investigated the interaction of the purified proteins D29DHODH and EcDHODH with supported lipid bilayers of different compositions using QCM-D. Figure 3 shows QCM-D traces with Df and DD curves for D29DHODH on 4 different lipid bilayers containing representative lipids present in the IMM (POPC, TOCL and ubiquinone Q 10 ). QCM-D traces corresponding to EcDHODH on four equivalent lipid bilayers are displayed in Supplementary  Figure 2 . The parameters obtained for these experiments are listed in Table 2 . A typical supported lipid bilayer (SLB) consisting only of POPC is expected to have a Df value of about À25 Hz and a DD value of about 0-0.5 Â 10 À6 at full surface coverage. As can be observed in Table 2 , the changes in frequency and dissipation for bilayers of POPC are consistent with those expected for a typical SLB. However, the incorporation of TOCL and Q 10 results in slightly higher frequency and dissipation changes, indicating that the bilayer deposited on the crystal surface contains more mass and is less rigid, with possibly some intact lipid vesicles still attached.
Both D29DHODH and EcDHODH display a low affinity for bilayers consisting of either pure POPC or POPC þ Q 10 , as evidenced by the small decreases in frequency corresponding to only a small mass of protein adsorbed onto the bilayers ( Table 2 ). Rinsing with buffer removes a substantial amount of the initially adsorbed protein in the case of POPC bilayers, and virtually all of the bound protein in the case of POPC þ Q 10 . This suggests that the presence of Q 10 does not increase affinity of either of the proteins. On the other hand, the presence of TOCL promotes a much stronger interaction between both proteins and the bilayer, as evidenced by the significant decrease in frequency (and increase in mass) after protein addition. In the case of D29DHODH, rinsing removes most (84%) of the initially adsorbed protein. However, rinsing removes only 33% of the adsorbed EcDHODH, suggesting that the interaction between the bacterial protein and the bilayer is more stable. In the case of bilayers containing POPC þ TOCL þ Q 10 , D29DHODH displays an even higher affinity. The bacterial protein also displays significant binding, although to a lesser extent than the human version. However, it should be noted that only 19% of the initially bound D29DHODH remains after rinsing whereas most of the bacterial protein (87%) remains bound.
While D29DHODH and EcDHODH can be injected over a pre-formed lipid bilayer and their interactions with the lipid bilayer characterized by QCM-D, full-length DHODH needs to be reconstituted in the lipid bilayer using an appropriate solubilizing carrier. Experiments addressing this method development are currently ongoing and shortly discussed below.
Discussion
While our D29DHODH and EcDHODH preparations show similar specific activities as reported for comparable protein preparations previously, [4, 20] full-length DHODH, despite being apparently homogenous after purification (Figure 2 ), shows lower specific activity than similar constructs previously reported. [18] In order to reconstitute DHODH into planar lipid membranes, we are using the common membrane-protein solubilizing Table 2 . QCM À D parameters obtained for D29DHODH and EcDHODH (in brackets) using 4 different lipid bilayer compositions. The lipid compositions were as follows: 100 mol% POPC, 90 mol% POPC þ 10% Q 10 , 90 mol% POPC þ 10% TOCL, and 80 mol% POPC þ 10% Q 10 þ 10% TOCL. The change in frequency (Df), dissipation (DD) and mass (Dm) are indicated. The values shown represent the average of at least 2 independent measurements. The frequency and dissipation values shown correspond to the 7th overtone. Changes in mass were calculated by means of viscoelastic (Voigt) modeling using the Dfind software package (Biolin Scientific). Parameters for the lipid bilayer were calculated with respect to the quartz crystal surface (baseline). Parameters for the protein, both before and after rinse, were calculated with respect to the deposited lipid bilayer. detergent DDM, which we have previously developed into a platform for reconstituting planar lipid bilayers that are detergent-free. [21] For this purpose, we solubilized our full length DHODH with DDM instead of Triton X-100, as previously reported, [18] and the lower specific activity of the enzyme might highlight the role of the environment of the TM and membrane interacting parts for DHODH activity. We plan to follow up this observation with different DHODH formulations in order to characterize the effect of different detergents and lipid additions on its kinetic parameters.
To the best of our knowledge, we describe here for the first time the interactions between DHODH and lipid bilayers using QCM-D. We have chosen to compare N-terminally truncated human DHODH (D29DHODH) and EcDHODH, which naturally lacks a TM domain but uses also ubiquinone as an electron acceptor.
QCM-D analysis shows that the presence of TOCL in the bilayers significantly enhances the binding between the bilayer and truncated human DHODH. Addition of Q 10 does not have a detectable effect when compared to bilayers consisting only of POPC. TOCL also promotes binding between the bilayer and bacterial DHODH. The interaction between the lipids and D29DHODH is mostly transient, as rinsing removes most of the initially bound protein. This might suggest that the N-terminal segments (MS and TM) are required for stable binding and securing its location at the outer surface of the IMM (Figure 1 ). On the other hand, the lipid interaction of the naturally soluble EcDHODH is more stable, as less of the initially bound protein is removed by rinsing.
Phosphatidylcholines such as POPC are zwitterionic molecules with a net neutral charge, but cardiolipins like TOCL are anionic lipids. We observed the largest effects on DHODH binding by incorporation of TOCL to our SLBs. The affinity between TOCL and DHODH could be explained by electrostatic interactions between the negatively charged phosphate groups in TOCL and positively charged residues found in the alpha-helical microdomains of both D29DHODH and EcDHODH. The effect of incorporating Q 10 in the SLB was less pronounced than that of TOCL. Previous studies [8] have indicated that Q 10 mostly localizes to the hydrophobic center of the lipid bilayer (Figure 1 ), between the two lipid leaflets, which might limit its ability to bind to DHODH. How DHODH interacts with and transfers electrons to the membrane-embedded Q 10 is therefore still an open question that we hope to address with future NR studies.
